AKT1 and esophageal squamous cell carcinoma: Small molecule inhibitor NCT-501 down-regulated ALDH1A1 expression and inhibited AKT-β-catenin signaling pathway, and the proliferation of esophageal squamous cell carcinoma cells 29.